OBJECTIVE: To evaluate the clinical effectiveness of programmable valves compared with non-programmable valves of hydrocephalus. METHODS: In this paper, the authors report a systematic review and meta-analysis of complications and revision rate for programmable valves and non-programmable implantation. Randomized or non-randomized controlled trials of hydrocephalus treated by programmable and non-programmable valves were considered for inclusion. RESULTS: Seven published reports of eligible studies involving 1702 participants meet the inclusion criteria. Compared with non-programmable, programmable valves had no significant difference in catheter-related complications [RR = 0.88, 95%CI (0.66,1.19), p = 0.10] and infection rate [RR = 1.25, 95%CI (0.92,1.69), p = 1.00]. There were significant differences in overall complications [RR = 0.80, 95%CI (0.67,0.96), p < 0.01], over-drainage or under-drainage complications [RR = 0.44, 95%CI (0.31,0.63), p < 0.01] and revision rate [RR = 0.56, 95%CI (0.45,0.69), p < 0.01] in favor of programmable valves. CONCLUSION: Although the studies seem to demonstrate a small advantage for the programmable shunts, the probable bias and the difficulties in patient selection are too important to make a general conclusion.
OBJECTIVE: To evaluate the clinical effectiveness of programmable valves compared with non-programmable valves of hydrocephalus. METHODS: In this paper, the authors report a systematic review and meta-analysis of complications and revision rate for programmable valves and non-programmable implantation. Randomized or non-randomized controlled trials of hydrocephalus treated by programmable and non-programmable valves were considered for inclusion. RESULTS: Seven published reports of eligible studies involving 1702 participants meet the inclusion criteria. Compared with non-programmable, programmable valves had no significant difference in catheter-related complications [RR = 0.88, 95%CI (0.66,1.19), p = 0.10] and infection rate [RR = 1.25, 95%CI (0.92,1.69), p = 1.00]. There were significant differences in overall complications [RR = 0.80, 95%CI (0.67,0.96), p < 0.01], over-drainage or under-drainage complications [RR = 0.44, 95%CI (0.31,0.63), p < 0.01] and revision rate [RR = 0.56, 95%CI (0.45,0.69), p < 0.01] in favor of programmable valves. CONCLUSION: Although the studies seem to demonstrate a small advantage for the programmable shunts, the probable bias and the difficulties in patient selection are too important to make a general conclusion.
Authors: David J Apigo; Philip L Bartholomew; Thomas Russell; Alokik Kanwal; Reginald C Farrow; Gordon A Thomas Journal: Sens Actuators A Phys Date: 2016-10-20 Impact factor: 3.407
Authors: David J Apigo; Philip L Bartholomew; Thomas Russell; Alokik Kanwal; Reginald C Farrow; Gordon A Thomas Journal: Sci Rep Date: 2017-04-05 Impact factor: 4.379
Authors: Luis Garegnani; Juan Va Franco; Agustín Ciapponi; Virginia Garrote; Valeria Vietto; Santiago Adalberto Portillo Medina Journal: Cochrane Database Syst Rev Date: 2020-06-16